Cargando…
Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
To ensure proper dosage of a drug, analytical quantification of it in biofluid is necessary. Liquid chromatography mass spectrometry (LC-MS) is the conventional method of choice as it permits accurate identification and quantification. However, it requires expensive instrumentation and is not approp...
Autores principales: | Yang, Huiyi, Qi, Meng, He, Qiyi, Hwang, Sung Hee, Yang, Jun, McCoy, Mark, Morisseau, Christophe, Zhao, Suqing, Hammock, Bruce D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568103/ https://www.ncbi.nlm.nih.gov/pubmed/37842656 http://dx.doi.org/10.1016/j.jpha.2023.05.006 |
Ejemplares similares
-
The Generation of a Nanobody-Based ELISA for Human Microsomal Epoxide Hydrolase
por: He, Qiyi, et al.
Publicado: (2023) -
Effects of Individual Circulating FFAs on Plasma and Hepatic FFA Epoxides, Diols, and Epoxide-Diol Ratios as Indices of Soluble Epoxide Hydrolase Activity
por: Oh, Young Taek, et al.
Publicado: (2023) -
Soluble Epoxide Hydrolase Contributes to Cell Senescence and ER Stress in Aging Mice Colon
por: Wang, Weicang, et al.
Publicado: (2023) -
Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
por: Wagner, Karen M., et al.
Publicado: (2021) -
Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty
Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018)